TBPN AI vs. Dog Cancer, Timothée Chalamet Under Fire, ‘Agents Over Bubbles' | Diet TBPN
52 snips
Mar 16, 2026 AI takes on dog cancer through personalized biotech and boundary-pushing treatment ideas. The conversation swings to Nvidia, AGI, and why software agents could spark a huge compute boom. There is also chatter about bargain Macs, Meta’s giant infrastructure bets, and the Timothée Chalamet opera backlash.
AI Snips
Chapters
Transcript
Episode notes
Easy AI Funding Means You Probably Didn't Push Hard Enough
- Jordy Hayes argues easy AI funding is not enough if capital truly shapes market outcomes.
- He highlights Travis Kalanick's line that if raising was easy and money matters, founders should have pushed for two or three times more.
AI Compressed A Personalized Dog Cancer Pipeline
- The Rosie story matters less as an instant AI cure and more as proof AI can compress a complex biotech workflow.
- Paul Coyningham used ChatGPT, sequencing, custom pipelines, and university partners to design a bespoke mRNA vaccine that shrank one tumor by half.
AI Could Turn Biotech Into A High Agency Craft
- AI may push biotechnology from centralized institutions toward motivated individuals who can navigate research themselves.
- John Coogan connects Freeman Dyson's domesticated biotech idea to a case where someone read every paper on a rare illness and found the one expert who cured it.